ConductScience.org, home

Paper39489491

Melanoma Diagnosis in the Mihm Era-And Beyond.

Elder DE. J Cutan Pathol, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Melanoma Diagnosis in the Mihm Era-And Beyond. Papers, record 39489491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39489491

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Melanoma Diagnosis in the Mihm Era-And Beyond.
PubMed
Journal
J Cutan Pathol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Historical Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-01-06
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Elder DEDavid Ehttps://orcid.org/0000-0003-4575-2364

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Skin NeoplasmsMajor topic
Humans
History, 20th Century
Overdiagnosis
History, 21st Century

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139026390Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia.Br J Dermatol2024https://conductscience.org/library/papers/39026390PubMed
229367314Overdiagnosis: what it is and what it isn't.BMJ Evid Based Med2018https://conductscience.org/library/papers/29367314PubMed
3602975Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma.Am J Surg Pathol1977https://conductscience.org/library/papers/602975PubMed
429141225A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.Cell Rep2017https://conductscience.org/library/papers/29141225PubMed
51468256Risk classification of life and health insurance applicants with atypical melanocytic hyperplasia or malignant melanoma in situ.Cutis1992https://conductscience.org/library/papers/1468256PubMed
628659278Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.BMJ2017https://conductscience.org/library/papers/28659278PubMed
76500548A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.Hum Pathol1984https://conductscience.org/library/papers/6500548PubMed
84053039Characteristics of cultured human melanocytes isolated from different stages of tumor progression.Cancer Res1985https://conductscience.org/library/papers/4053039PubMed
96528943Invasive malignant melanomas lacking competence for metastasis.Am J Dermatopathol1984https://conductscience.org/library/papers/6528943PubMed
1037938821Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions.JAMA Dermatol2023https://conductscience.org/library/papers/37938821PubMed
1130045064PRAME Expression in Melanocytic Tumors.Am J Surg Pathol2018https://conductscience.org/library/papers/30045064PubMed
12790575The developmental biology of primary human malignant melanomas.Semin Oncol1975https://conductscience.org/library/papers/790575PubMed
133980788No one should die of malignant melanoma.J Am Acad Dermatol1985https://conductscience.org/library/papers/3980788PubMed
1436642569Diagnostic error, uncertainty, and overdiagnosis in melanoma.Pathology2023https://conductscience.org/library/papers/36642569PubMed
1521497295Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma.J Mol Diagn2011https://conductscience.org/library/papers/21497295PubMed
1620413742Overdiagnosis in cancer.J Natl Cancer Inst2010https://conductscience.org/library/papers/20413742PubMed
1736336975Prognostic modeling of cutaneous melanoma stage I patients using cancer registry data identifies subsets with very-low melanoma mortality.Cancer2023https://conductscience.org/library/papers/36336975PubMed
1824910143Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.Br J Dermatol2015https://conductscience.org/library/papers/24910143PubMed
1929579032Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis.Plast Reconstr Surg2018https://conductscience.org/library/papers/29579032PubMed
2010333228Progression-related expression of beta3 integrin in melanomas and nevi.Hum Pathol1999https://conductscience.org/library/papers/10333228PubMed

See all 39 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
39489491Melanoma Diagnosis in the Mihm Era-And Beyond.J Cutan Pathol2026https://conductscience.org/library/papers/39489491

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39489491

GET https://conductscience.org/api/papers/v1/39489491/references?page=2